奧貝膽酸雜質(zhì)，奧美拉唑雜質(zhì)對照品 產(chǎn)品介紹：
中文名稱：奧貝膽酸雜質(zhì)，奧美拉唑雜質(zhì)對照品
英文名稱：
規(guī)格：10mg/25mg/50mg/100mg等多種規(guī)格可選。
用途：實(shí)驗研發(fā)，藥品申報檢測，不得用于臨床醫(yī)學(xué)診斷。
隨貨提供：所有雜質(zhì)對照品均隨貨提供HPLC，NMR，MS圖譜及CoA證書。
保存及取用：為了防止產(chǎn)品含量降低，應(yīng)防潮，避光和抗氧化包裝，保存應(yīng)以提高物質(zhì)穩(wěn)定性為原則。如果一次使用很少量，可以將其適當(dāng)分裝后使用，這樣可以有效的防止試劑污染。請不要在臟亂和強(qiáng)光環(huán)境中取用，以免造成污染和失效。

奧貝膽酸雜質(zhì)，奧美拉唑雜質(zhì)對照品 雜質(zhì)列表：

Obeticholic Acid	(4R)-4-((3R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Obeticholic Acid Impurity 1	(R)-4-((3R,5S,6R,7S,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Obeticholic Acid Impurity 2	(R)-4-((3R,5S,6S,7S,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Obeticholic Acid Impurity 3	(R)-4-((3R,5S,6S,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Obeticholic Acid Impurity 4	(R)-4-((3R,5S,6S,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Obeticholic Acid Impurity 5	(4R)-4-((3R,5S,6R,7R,9S,10S,13R,14S,17R)-6-ethyl-3-(((R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)oxy)-7-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Obeticholic Acid Impurity 6	(R)-4-((3R,5R,7S,8S,9S,10R,13R,14S,17R,E)-6-ethylidene-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Obeticholic Acid Impurity 7	(R)-4-((5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7-dioxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Obeticholic Acid Impurity 8	(R)-methyl 4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
Obeticholic Acid Impurity 9	(R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Obeticholic Acid Impurity 10	(R)-4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
Obeticholic Acid Impurity 11	(R)-methyl 4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
Omeprazole	LCZ 696
Omeprazole Impurity A	5-Methoxy-1Hbenzimidazole-2-thiol
Omeprazole Impurity B	2-(((3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d]imidazole	4-Desmethoxy Omeprazole
Omeprazole Impurity C	5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole	Omeprazole Sulfide
Omeprazole Impurity D	5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole	Omeprazole Sulphone
Omeprazole Impurity E	4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridine 1-oxide	Omeprazole N-Oxide
Omeprazole Impurity F	8-methoxy-1,3-dimethyl-12-thioxobenzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridin-2(12H)-one
Omeprazole Impurity G	9-methoxy-1,3-dimethyl-12-thioxobenzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridin-2(12H)-one
Omeprazole Impurity H	2-(((4-chloro-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d]imidazole	4-Desmethoxy-4-chloro Omeprazole
Omeprazole Impurity I	4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfonyl)methyl)-3,5-dimethylpyridine 1-oxide	Omeprazole Sulphone N-Oxide

若雜質(zhì)列表中未有您需要的雜質(zhì)，歡迎來電或在線詳詢，產(chǎn)品庫時常會有更新，另外，我司有專業(yè)研發(fā)團(tuán)隊，可提供部分雜質(zhì)定制服務(wù)，以最大可能的滿足您對雜質(zhì)對照品的選購需求。

奧貝膽酸雜質(zhì)，奧美拉唑雜質(zhì)對照品 訂購方式：
聯(lián)系人：何先生
手機(jī)：15012456311
QQ：781007885
郵箱：phastandards@gmail.com
歡迎您通過電話，電郵或在線客服向我司詢價及訂購產(chǎn)品。

奧貝膽酸雜質(zhì)，奧美拉唑雜質(zhì)對照品 深圳遠(yuǎn)揚(yáng)專注醫(yī)藥標(biāo)準(zhǔn)品，雜質(zhì)對照品，更多產(chǎn)品，歡迎選購（篇幅有限，只列舉了一小部分，更多更全，請來電詳詢）：
NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表：

12/B623-050       QCRFLUAH1N1QC1-Influenza AH1N1 QC48

13/142               Influenza Antigen B/Massachusetts/02/2020 (Egg derived)

13/227               C-Peptide, Human. 82st International Standard.

03/104-044         HTLV-29 (antibody) Monitor Sample

12/B623-009       QCRFLUAH1N1QC1-Influenza AH1N1 QC7

01/479               Meningococcal serogroup W polysaccharide

13/173               C-Peptide, Human. 28st International Standard.

10/199               Reteplase Reference Material

07/378               BCG Vaccine of Russian BCG-I sub-strain(105st WHO Reference Reagent)

13/161               C-Peptide, Human. 16st International Standard.

03/104-102         HTLV-87 (antibody) Monitor Sample

13/273               Polio Anti Sabin type 56 (inactivated) Serum

12/B623-074       QCRFLUAH1N1QC1-Influenza AH1N1 QC72

01/511               Meningococcal serogroup W polysaccharide

13/234               C-Peptide, Human. 89st International Standard.

07/336               BCG Vaccine of Russian BCG-I sub-strain(63st WHO Reference Reagent)

10/149               Reteplase Reference Material

13/251               C-Peptide, Human. 106st International Standard.

12/B623-044       QCRFLUAH1N1QC1-Influenza AH1N1 QC42

95/622               Interleukin-83 (Human, rDNA derived)

07/357               BCG Vaccine of Russian BCG-I sub-strain(84st WHO Reference Reagent)

03/104-085         HTLV-70 (antibody) Monitor Sample

10/144               Reteplase Reference Material

07/331               BCG Vaccine of Russian BCG-I sub-strain(58st WHO Reference Reagent)

07/304               BCG Vaccine of Russian BCG-I sub-strain(31st WHO Reference Reagent)

01/532               Meningococcal serogroup W polysaccharide

10/166               Reteplase Reference Material

10/177               Reteplase Reference Material

10/162               Reteplase Reference Material

95/581               Interleukin-42 (Human, rDNA derived)

13/325               Polio Anti Sabin type 108 (inactivated) Serum

03/104-041         HTLV-26 (antibody) Monitor Sample

95/653               Interleukin-114 (Human, rDNA derived)

10/185               Reteplase Reference Material

01/440               Meningococcal serogroup W polysaccharide

07/279               BCG Vaccine of Russian BCG-I sub-strain(6st WHO Reference Reagent)

03/104-120         HTLV-105 (antibody) Monitor Sample

95/651               Interleukin-112 (Human, rDNA derived)

雜質(zhì)對照品部分產(chǎn)品列表：
吡侖帕奈雜質(zhì)，米托蒽醌雜質(zhì)，帕瑞昔布雜質(zhì)，鹽酸厄洛替尼雜質(zhì)，尼美舒利雜質(zhì)，坎格列嗪雜質(zhì)，奧拉西坦雜質(zhì)，多潘立酮雜質(zhì)，枸櫞酸阿爾維林雜質(zhì)，蓓薩羅丁雜質(zhì)，貝凡洛爾雜質(zhì)，米格列奈雜質(zhì)，美托咪定雜質(zhì)，米格列醇雜質(zhì)，奧扎格雷雜質(zhì)，阿格列汀雜質(zhì)，硝苯地平雜質(zhì)，可樂定雜質(zhì)，他克莫司雜質(zhì)，凡德他尼雜質(zhì)，甲磺酸多沙唑嗪雜質(zhì)，米諾地爾雜質(zhì)，沙芬酰胺雜質(zhì)，馬來酸依拉普利雜質(zhì)，洛沙坦雜質(zhì)，厄貝沙坦雜質(zhì)，維莫德吉雜質(zhì)，法羅培南雜質(zhì)，索非布韋雜質(zhì)，咪喹莫特雜質(zhì)，魯索替尼雜質(zhì)，唑吡坦雜質(zhì)，達(dá)沙替尼雜質(zhì)，瑞替加濱雜質(zhì)，伯森坦雜質(zhì)，考尼伐坦雜質(zhì)，達(dá)拉非尼雜質(zhì)，布林佐胺雜質(zhì)，右旋雷貝拉唑雜質(zhì)，氨基磺酸雜質(zhì)，特力利汀雜質(zhì)，西維來司他雜質(zhì)，布拉地新雜質(zhì)，羅拉吡坦雜質(zhì)，左旋多巴雜質(zhì)，酮咯酸雜質(zhì)，托非索泮雜質(zhì)，去氨加壓素雜質(zhì)，坎地沙坦酯雜質(zhì)，沙格雷酯雜質(zhì)，富馬酸非索羅定雜質(zhì)，丁溴東莨菪堿雜質(zhì)，拉帕替尼雜質(zhì)，桂利嗪雜質(zhì)，氯美扎酮雜質(zhì)，托特羅定雜質(zhì)，氨甲環(huán)酸雜質(zhì)，依折麥布雜質(zhì)，雷奈酸鍶雜質(zhì)，鹽酸地爾硫卓雜質(zhì)，絲裂霉素雜質(zhì)，達(dá)卡他韋雜質(zhì)，美沙拉嗪雜質(zhì)，美曲普汀雜質(zhì)